Clinical Trial Update: Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders [Phase 3]

View source ↗

Summary

A Phase 3 multi-center trial evaluating anti-thymocyte globulin for aplastic anemia and related hematologic disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Pancytopenia

Drugs mentioned

• anti-thymocyte globulin (antithymocyte globulin)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Anemia, Aplastic, Hematologic Diseases | Phase 3 | Status: COMPLETED